Music Interventions in Epilepsy Management

Music interventions in epilepsy management encompass a spectrum of non-pharmacological strategies aimed at reducing seizure frequency, modulating epileptiform activity and improving quality of life. Initially popularised by observations of the “Mozart effect”, the field has evolved from anecdotal reports to controlled trials, meta-analyses and mechanistic studies. Listening to structured compositions, most notably Mozart’s Sonata for Two Pianos in D major (K.448), has been associated with transient reductions in seizure counts and interictal epileptiform discharges. Advances in digital health have enabled integration of music-based regimens within mobile applications and software as medical devices, facilitating personalised delivery, adherence monitoring and combination with behavioural therapies. Preclinical investigations in animal models have begun to elucidate underlying neural and autonomic pathways, suggesting modulation of cortical excitability and emotional networks. Collectively, these efforts underline the global significance of incorporating accessible, low-risk adjunctive treatments into comprehensive epilepsy care, particularly for individuals with drug-resistant forms and comorbidities.

Research from Nature Portfolio

Recent meta-analytic work employing multiverse analytical frameworks has rigorously reassessed the evidence for specific music effects on epilepsy. Analyses across multiple published studies demonstrated only trivial to small overall effects of listening to select compositions, with significant heterogeneity and inflated effect sizes driven by a limited number of underpowered trials. These findings call into question the specificity of any single musical stimulus and highlight the necessity for greater transparency and adequate statistical power in future investigations. Complementing these syntheses, intracranial monitoring studies have examined the acute impact of Mozart K.448 on interictal epileptiform discharges in patients with refractory focal epilepsy. High-resolution recordings revealed a rapid decrease in discharge rate after sustained exposure, accompanied by region-specific oscillatory changes in frontal networks. This work advances understanding of exposure-dependent dynamics and suggests that particular spectral and temporal features of music may play a key role in modulating epileptiform activity.

Music Interventions in Epilepsy Management publication trend

The graph below shows the total number of articles in music interventions in epilepsy management across all publications each year (not limited to Nature Index journals).

Technical terms

Interictal epileptiform discharges (IEDs): Transient abnormalities on electroencephalogram indicative of cortical hyperexcitability occurring between clinical seizures.

Software as a medical device (SaMD): Digital applications intended to diagnose, treat or manage medical conditions without being part of a hardware medical device.

Digital therapeutics: Evidence-based therapeutic interventions delivered through software to prevent, manage or treat diseases.

Randomised crossover design: A study format in which participants receive multiple interventions sequentially, allowing each individual to act as their own control.

References

1. Unfounded authority, underpowered studies, and non-transparent reporting perpetuate the Mozart effect myth: a multiverse meta-analysis. Scientific Reports (2023).
2. Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders. Frontiers in Human Neuroscience (2018).
3. Mozart K.448 listening decreased seizure recurrence and epileptiform discharges in children with first unprovoked seizures: a randomized controlled study. BMC Complementary Medicine and Therapies (2014).
4. Musical components important for the Mozart K448 effect in epilepsy. Scientific Reports (2021).
5. Music-Enhanced Analgesia and Antiseizure Activities in Animal Models of Pain and Epilepsy: Toward Preclinical Studies Supporting Development of Digital Therapeutics and Their Combinations With Pharmaceutical Drugs. Frontiers in Neurology (2019).